Twelve candidate aging rate indicators could offer faster route to testing geroprotective drugs – and to understanding what ...

Yale-led analysis harmonized 51 studies under one standardized pipeline, and senolytics came out looking shaky.

New Princeton lab gives skincare-focused biotech direct control over research behind its flagship rapalog serum, rather than ...

There was a ribbon, a crowd, the usual photo line-up of executives and officials. However, the more interesting detail from ...

PhytoGaia spotlights new clinical data on ingredients for healthy aging, liver support and, notably, pet wellness. Walk the ...

Phase 3 results presented in Munich and Barcelona show gains for two life-threatening conditions that quietly steal years ...

Mission Therapeutics pairs brain-penetrant mitochondria drug with NeuraLight’s eye-tracking biomarkers in a multi-country ...

The company has launched The Elysium Longevity Institute, a physician-led clinical program meant to bring rigor to a field ...

After reconsidering, Canada’s Drug Agency issued a final recommendation supporting public reimbursement of lecanemab, sold as ...

Durham University spinout Magnitude Biosciences raises $1.3 million to scale a platform that screens drugs in living worms, ...

Company bets that AI-assisted analysis and a leaner trial design can get PrimeC to patients years sooner than the usual ...

Insilico’s new program combines AI, circular mRNA and in vivo T-cell engineering to target early cellular drivers of age-related disease. The approach is less conventional vaccination than ...